Publication | Closed Access

Circulating CD4+PD-1+ and CD8+PD-1+ T cells are profoundly decreased at the onset of fulminant type 1 diabetes and are restored by treatment, contrasting with CD4+CD25+FoxP3+ regulatory T cells

Diabetes ManagementAutoimmune DiseaseFulminant Type 1T-regulatory CellDiabetesImmunologyPathologyAutoimmunityDiabetes MellitusCd8+pd-1+ T CellsImmunotherapyMedicine